查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498731

鱼疫苗市场，按疫苗类型、适应症、给药途径、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Fish Vaccines Market, By Vaccine Type, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年鱼疫苗市场规模为3.824亿美元，2024年至2032年复合年增长率为7.40%。

鱼类疫苗市场-市场动态

水产养殖活动的增加推动鱼类疫苗市场的成长

水产养殖活动的激增极大地推动了鱼疫苗市场的成长。根据粮食及农业组织(FAO) 的数据，全球水产养殖产量一直在稳步增长，预计到2030 年将达到1.09 亿吨。有效的健康管理实践确保可持续的产量。例如，鲑鱼养殖领先国家挪威已大量采用鱼类疫苗对抗传染性鲑鱼贫血症和鱼类正呼肠病毒等疾病，从而提高了生产效率。这些趋势凸显了疫苗在维持鱼类健康和支持水产养殖业蓬勃发展的关键角色。

鱼疫苗市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 7.40% 左右的复合年增长率成长

根据疫苗类型细分，减毒疫苗预计将在 2023 年占据最大市场份额

依主治细分，2023年疖病为主导类型

根据给药途径细分，2023年口服是领先类型

按地区划分，欧洲是 2023 年的主要收入来源

鱼疫苗市场-区隔分析：

全球鱼疫苗市场根据疫苗类型、适应症、给药途径、最终用户和地区进行细分。

根据疫苗类型，市场分为七类：灭活疫苗、灭活疫苗、减毒疫苗、类毒素疫苗、次单位疫苗、合併疫苗和重组载体疫苗。减毒疫苗因其能有效诱发强烈且持久的免疫反应而引领鱼疫苗市场。随后出现灭活疫苗，提供安全性和稳定性。灭活疫苗、次单位疫苗和类毒素疫苗满足特定需求，而结合疫苗和重组载体疫苗代表了具有先进免疫技术的新兴领域。

市场依适应症分为四类：疖病、弧菌病、耶尔森氏菌病、肠道败血症。由于疖病的广泛流行和对鲑鱼的重大影响，疖病在鱼疫苗市场上占据主导地位。弧菌病随之而来，影响全球多种鱼类。耶尔森氏菌病和肠道败血症也占有相当大的市场份额，针对水产养殖中的特定细菌感染。

鱼疫苗市场 - 地理洞察

欧洲引领市场，尤其是挪威和苏格兰等国家，因为它们拥有先进的水产养殖业和高度鱼类疫苗接种做法。北美，特别是美国和加拿大，在广泛的鲑鱼和鳟鱼养殖的推动下也显示出显着的市场成长。在亚太地区，由于水产养殖产量的增加和鱼类健康管理意识的提高，中国、印度和越南等国家正在经历快速的市场扩张。拉丁美洲、中东和非洲是新兴市场，受到水产养殖基础设施投资不断增长以及政府促进永续养鱼做法的倡议的支持。

鱼疫苗市场-竞争格局：

Zoetis Inc.、Merck & Co, Inc.（透过其子公司 MSD Animal Health）、Elanco Animal Health 和 HIPRA 等领先公司透过提供针对各种鱼类疾病的多样化疫苗组合占据市场主导地位。这些公司专注于研发，推出新的、更有效的疫苗，改进疫苗输送方法，并透过策略合作伙伴关係和收购扩大其地理覆盖范围。例如，硕腾收购 Fish Vet Group 透过增强其诊断能力和疫苗产品，巩固了其在市场上的地位。此外，公司和学术机构之间的合作也很普遍，旨在推进疫苗技术并解决新出现的鱼类疾病。例如，2023 年 3 月，印度免疫学 (IIL) 与中央淡水水产养殖研究所 (CIFA) 合作，对淡水鱼出血性败血症疫苗进行商业开发。此外，规模较小的区域性参与者也透过满足当地的特定需求和监管要求来为市场做出贡献。

最近的发展：

2022年11月，印度免疫学公司（IIL）计画推出鱼类疫苗，标誌着其进军水产养殖市场。该疫苗将与中央渔业教育研究所（CIFE）合作开发，用于治疗淡水鱼的细菌性疾病，例如柱状桿菌病和爱德华氏菌病。

2024 年 5 月，HIPRA 宣布在地中海地区推出 ICTHIOVAC VNN，这是一种针对鲈鱼病毒性神经坏死 (VNN) 的灭活疫苗。该疫苗旨在保护鲈鱼免受 VNN 的侵害，VNN 是影响该地区水产养殖业的重大疾病

目录

第 1 章：鱼疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疫苗类型分類的鱼疫苗市场片段
    • 鱼疫苗市场片段（按适应症）
    • 依给药途径分類的鱼疫苗市场片段
    • 最终用户的鱼疫苗市场片段
    • 按国家/地区分類的鱼疫苗市场摘要
    • 按地区分類的鱼疫苗市场片段
  • 竞争洞察

第 3 章：鱼疫苗主要市场趋势

  • 鱼类疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 鱼疫苗市场限制
    • 市场限制影响分析
  • 鱼疫苗市场机会
  • 鱼疫苗市场未来趋势

第 4 章：鱼疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：鱼疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：鱼疫苗市场格局

  • 2023 年鱼疫苗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：鱼疫苗市场 - 依疫苗类型

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 灭活疫苗
    • 灭活疫苗
    • 减毒疫苗
    • 类毒素疫苗
    • 亚单位疫苗
    • 结合疫苗
    • 重组载体疫苗

第 8 章：鱼疫苗市场 - 依适应症分类

  • 概述
    • 按指标分類的细分市场占有率分析
    • 疖病
    • 弧菌病
    • 耶尔森氏菌病
    • 肠败血症
    • 其他的

第 9 章：鱼疫苗市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 注射
    • 浸没
    • 喷
    • 口服

第 10 章：鱼疫苗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 水产养殖场
    • 孵化场
    • 研究机构

第 11 章：鱼疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美鱼疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疫苗类型）
    • 北美市场规模和预测（按指标）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲鱼疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按疫苗类型）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区鱼疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依疫苗类型）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲鱼疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疫苗类型）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲鱼疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疫苗类型）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 鱼疫苗产业

  • 竞争仪表板
  • 公司简介
    • Aleph Farms
    • BioMar Group
    • Ceva Sante Animale
    • Elanco Animal Health (part of Eli Lilly and Company)
    • Fish Vet Group (part of Benchmark Holdings plc)
    • HIPRA
    • Hipra Animal Health Limited
    • Intervet Inc. (part of Merck & Co., Inc.)
    • Merck Animal Health (part of Merck & Co., Inc.)
    • MSD Animal Health (part of Merck & Co., Inc.)
    • Nisseiken Co., Ltd.
    • Syndel Laboratories
    • Vaxxinova
    • Vetech Laboratories
    • Vetoquinol SA
    • Zoetis Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2900

REPORT HIGHLIGHT

Fish Vaccines Market size was valued at USD 382.40 million in 2023, expanding at a CAGR of 7.40% from 2024 to 2032.

The Fish Vaccines Market involves the development and distribution of vaccines aimed at preventing diseases in fish populations, crucial for aquaculture health management. The increasing demand for fish protein, rising aquaculture practices, and advancements in vaccine technologies are growth factors in the market. Additionally, growing awareness about sustainable aquaculture and the need to reduce antibiotic usage in fish farming further bolsters the market. However, challenges such as high vaccine development costs, regulatory hurdles, and limited access to vaccines in developing regions restrain growth. Opportunities lie in the expansion of aquaculture in emerging markets, innovation in vaccine delivery methods, and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Market Dynamics

Rising Aquaculture Activities Propel Growth in the Fish Vaccines Market

The surge in aquaculture activities is significantly driving the growth of the Fish Vaccines Market. According to the Food and Agriculture Organization (FAO), global aquaculture production has been steadily increasing and is projected to reach 109 million tonnes in 2030. This expansion is fueled by the growing demand for fish as a protein source, necessitating effective health management practices to ensure sustainable yields. For instance, Norway, a leading country in salmon farming, has seen substantial adoption of fish vaccines to combat diseases like infectious salmon anemia and piscine orthoreovirus, enhancing production efficiency. Such trends highlight the crucial role of vaccines in maintaining fish health and supporting the thriving aquaculture industry.

Fish Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Attenuated Vaccine was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Furunculosis was the leading type in 2023

Based on Route of Administration segmentation, Oral was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Fish Vaccines Market- Segmentation Analysis:

The Global Fish Vaccines Market is segmented on the basis of Vaccine Type, Indication, Route of Administration, End-User, and Region.

The market is divided into seven categories based on Vaccine Type: Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccines. Attenuated vaccines lead the Fish Vaccines Market due to their effectiveness in inducing strong and long-lasting immune responses. Inactivated vaccines follow, offering safety and stability. Killed vaccines, subunit vaccines, and toxoid vaccines cater to specific needs, while conjugate and recombinant vector vaccines represent emerging segments with advanced immunization techniques.

The market is divided into four categories based on Indication: Furunculosis, Vibriosis, Yersiniosis, and Enteric septicaemia. Furunculosis dominates the Fish Vaccines Market due to its widespread prevalence and significant impact on salmonids. Vibriosis follows, affecting various fish species globally. Yersiniosis and enteric septicaemia also hold substantial market shares, targeting specific bacterial infections in aquaculture.

Fish Vaccines Market- Geographical Insights

Europe leads the market, particularly countries like Norway and Scotland, due to their advanced aquaculture industries and high adoption of fish vaccination practices. North America, notably the United States and Canada, also shows significant market growth driven by extensive salmon and trout farming. In the Asia-Pacific region, countries such as China, India, and Vietnam are experiencing rapid market expansion due to increasing aquaculture production and rising awareness about fish health management. Latin America and the Middle East & Africa are emerging markets, supported by growing investments in aquaculture infrastructure and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Competitive Landscape:

Leading companies such as Zoetis Inc., Merck & Co., Inc. (through its subsidiary MSD Animal Health), Elanco Animal Health, and HIPRA dominate the market by offering a diverse portfolio of vaccines targeting various fish diseases. These companies focus on research and development to introduce new and more effective vaccines, improve vaccine delivery methods, and expand their geographical reach through strategic partnerships and acquisitions. For instance, Zoetis's acquisition of Fish Vet Group has strengthened its position in the market by enhancing its diagnostic capabilities and vaccine offerings. Additionally, collaboration between companies and academic institutions is prevalent, aiming to advance vaccine technology and address emerging fish diseases. For instance, in March 2023, Indian Immunologicals (IIL) partnered with the Central Institute of Freshwater Aquaculture (CIFA) for the commercial development of a vaccine against hemorrhagic septicemia in freshwater fish. Furthermore, smaller, regional players also contribute to the market by catering to specific local needs and regulatory requirements.

Recent Developments:

In November 2022, Indian Immunologicals (IIL) planned to launch a fish vaccine, marking its entry into the aquaculture market. The vaccine will be developed in partnership with the Central Institute of Fisheries Education (CIFE) for bacterial diseases in freshwater fish, such as Columnaris Disease and Edwardsiellosis.

In May 2024, HIPRA, announced the launch of ICTHIOVAC VNN, an inactivated vaccine against Viral Nervous Necrosis (VNN) in sea bass, in the Mediterranean region. This vaccine is designed to protect sea bass against VNN, a significant disease affecting the aquaculture industry in the region

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FISH VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aleph Farms

BioMar Group

Ceva Sante Animale

Elanco Animal Health (part of Eli Lilly and Company)

Fish Vet Group (part of Benchmark Holdings plc)

HIPRA

Hipra Animal Health Limited

Intervet Inc. (part of Merck & Co., Inc.)

Merck Animal Health (part of Merck & Co., Inc.)

MSD Animal Health (part of Merck & Co., Inc.)

Nisseiken Co., Ltd.

Syndel Laboratories

Vaxxinova

Vetech Laboratories

Vetoquinol S.A.

Zoetis Inc.

Others

GLOBAL FISH VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines

GLOBAL FISH VACCINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Furunculosis
  • Vibriosis
  • Yersiniosis
  • Enteric septicaemia
  • Others

GLOBAL FISH VACCINES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Injection
  • Immersion
  • Spray
  • Oral

GLOBAL FISH VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Aquaculture Farms
  • Hatcheries
  • Research Institutes

GLOBAL FISH VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fish Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fish Vaccines Market Snippet by Vaccine Type
    • 2.1.2. Fish Vaccines Market Snippet by Indication
    • 2.1.3. Fish Vaccines Market Snippet by Route of Administration
    • 2.1.4. Fish Vaccines Market Snippet by End-User
    • 2.1.5. Fish Vaccines Market Snippet by Country
    • 2.1.6. Fish Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Fish Vaccines Key Market Trends

  • 3.1. Fish Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fish Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fish Vaccines Market Opportunities
  • 3.4. Fish Vaccines Market Future Trends

4. Fish Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fish Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Fish Vaccines Market Landscape

  • 6.1. Fish Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fish Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Killed Vaccine
    • 7.1.3. Inactivated Vaccine
    • 7.1.4. Attenuated Vaccine
    • 7.1.5. Toxoid Vaccine
    • 7.1.6. Subunit Vaccine
    • 7.1.7. Conjugate Vaccine
    • 7.1.8. Recombinant Vector Vaccines

8. Fish Vaccines Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Furunculosis
    • 8.1.3. Vibriosis
    • 8.1.4. Yersiniosis
    • 8.1.5. Enteric septicaemia
    • 8.1.6. Others

9. Fish Vaccines Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Injection
    • 9.1.3. Immersion
    • 9.1.4. Spray
    • 9.1.5. Oral

10. Fish Vaccines Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Aquaculture Farms
    • 10.1.3. Hatcheries
    • 10.1.4. Research Institutes

11. Fish Vaccines Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Fish Vaccines Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Fish Vaccines Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Fish Vaccines Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Fish Vaccines Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Fish Vaccines Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Fish Vaccines Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Aleph Farms
    • 12.2.2. BioMar Group
    • 12.2.3. Ceva Sante Animale
    • 12.2.4. Elanco Animal Health (part of Eli Lilly and Company)
    • 12.2.5. Fish Vet Group (part of Benchmark Holdings plc)
    • 12.2.6. HIPRA
    • 12.2.7. Hipra Animal Health Limited
    • 12.2.8. Intervet Inc. (part of Merck & Co., Inc.)
    • 12.2.9. Merck Animal Health (part of Merck & Co., Inc.)
    • 12.2.10. MSD Animal Health (part of Merck & Co., Inc.)
    • 12.2.11. Nisseiken Co., Ltd.
    • 12.2.12. Syndel Laboratories
    • 12.2.13. Vaxxinova
    • 12.2.14. Vetech Laboratories
    • 12.2.15. Vetoquinol S.A.
    • 12.2.16. Zoetis Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Fish Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Fish Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Fish Vaccines Market, by Indication 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Fish Vaccines Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Fish Vaccines Market, by End-User 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Fish Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by End-User, 2019-2032 (USD Million)